Hemab Therapeutics Holdings, Inc.
NASDAQCOAG enters its August 20 earnings date having more than doubled the pace of its short position in a month — yet the stock keeps climbing anyway. The most striking dynamic on Hemab Therapeutics this week is a simultaneous lift in both the bull and bear camps. The stock is up 11% over the past five days and 36% over the past month, closing Tuesday at $51.74. At the same moment…
COAG short interest falls 37% in one week to 1.53M shares, though stock rallies 32% and analysts raise targets above $50.
COAG enters its August 20 earnings date having more than doubled the pace of its short position in a month — yet the stock keeps climbing anyway. The most striking dynamic on Hemab Therapeutics this week is a…
COAG enters the week with an unusual split: Wall Street initiated coverage with near-uniform bullishness just weeks ago, yet short sellers have been quietly building positions at a pace that stands out for such a newly…
Snapshot as of 16 Sept 2026
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for COAG — free to start on ORTEX.
Sign up for free →Open COAG on ORTEX